Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Glioblastoma × pembrolizumab × Clear all

Status

Recruiting 11 Completed 9 Active not recruiting 6 Unknown 3 Terminated 3 Withdrawn 2 Not yet recruiting 2 Suspended 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 2 Glioma 1 Glioblastoma 1

Interventions

rindopepimut 1 pembrolizumab 1 mogamulizumab 1 efineptakin alfa 1 Ipilimumab 1 Cancer Vaccines 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡